Authors
Loading...
In vitro genetic screen uncovers host genes restricting nonviral editing delivery in human cells, indicating targets to boost therapeutic editing efficiency.
Saxena et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: